This smallcap mutual fund added 12 new stocks in February while exiting 7 others

Bandhan Small Cap Fund-Reg(G) scheme, which boasts of the highest 1-year returns among smallcap mutual fund peers, significantly rejigged its portfolio in February with a dozen new stocks making their way into the scheme while seven stocks making a complete exit.

The scheme is benchmarked against S&P BSE 250 Smallcap TRI which has delivered returns of 63.32% over a 1-year period.

In value terms, the fund took the highest exposure in Juniper Hotels, buying shares worth over Rs 30.70 crore. It was followed by Eureka Forbes (Rs 29.63) and The South Indian Bank (Rs 27.83 crore).


Here is a complete list of the stocks that were bought in February by this fund:


Among the stocks sold was Glenmark Life Sciences, wherein the MF house sold shares worth Rs 13.56 crore, the highest in the pack. It was followed by IDFC (Rs 12.90 crore) and Concord Biotech (Rs 5.96 crore).

Here is a complete list of the stocks that were sold in full by this fund:


The Ace Equities data showed that there were 134 other stocks in the Bandhan Small Cap Fund-Reg(G) portfolio in February which were present in January as well. In this, Bandhan bought additional shares in 27 stocks in February, including Artemis Medicare Services, Arvind, BSE, CESC, Cyient, eClerx Services and Fed Bank Financial. It offloaded partial stakes in 31 stocks such as Avanti Feeds, Bank of India Coal India, IREDA CAMS and Zomato.

As of February 29, 2024, its top holdings were state-run REC, Arvind, Apar Industries and Cholamandalam Financial Holdings. They contributed over 2% of the fund’s net asset value (NAV).

The scheme was launched in February 2020 and currently manages assets worth Rs 4,389.28 crore.

Also Read: Focused vs thematic funds: Who holds the edge and top 5 funds in each category

Inputs from Surbhi Khanna

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)